TAN, ZILONG – Trademark Portfolio

Entity Type: 01

TAN, ZILONG holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include KETAN. The owner is based in JI 'AN CITY, JIANGXI.

NO.43 TANJIA GROUP, HUTIAN VILLAGE

LONGTIAN TOWNSHIP, YONGXIN COUNTY

JI 'AN CITY, JIANGXI 343000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KETAN
KETAN
Registered 2025
KETAN
KETAN
Registered 2020

Trademark Classifications

TAN, ZILONG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does TAN, ZILONG have?

TAN, ZILONG has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does TAN, ZILONG file in?

TAN, ZILONG files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are TAN, ZILONG's most well-known trademarks?

TAN, ZILONG's registered trademark portfolio includes well-known marks such as KETAN. These are among 2 currently registered trademarks in the portfolio.

What is TAN, ZILONG's trademark registration success rate?

TAN, ZILONG has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.